Skip to main content
Caplight Logo









DuraVax Inc.

DuraVax Inc.

Private
Wilmington, North CarolinaHealthcare & Life Scienceshttps://www.duravax.tech/

Last Round

Grant

May 1, 2024

Total Funding Raised

$274,991

Company Overview

DuraVax Inc. is a biotechnology company that develops stabilized biological formulation technologies to eliminate cold-chain requirements for mRNA vaccines and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

mRNA stabilizationthermostable vaccinecold chain logisticsbiotech platformlipid nanoparticlesvaccine formulationcold chaindrug deliverypharmaceutical manufacturingbiotech startupvaccine techroom temperature storagebiopharmavaccine supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DuraVax Inc. Comparables

Compare DuraVax Inc. with similar companies based on industry and business-model similarity.

DuraVax Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnsiliTech
80%
Stablepharma
80%
VitriVax, Inc.
77%

DuraVax Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2024
GrantApr 4, 2024

DuraVax Inc. Investors

Notable investors and investment history

DuraVax Inc. investors
InvestorRounds
NCInnovationGrant
North Carolina Biotechnology CenterGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2024

    Received grant funding from NCInnovation.

  • Apr 4, 2024

    $275K grant from National Science Foundation and others.

DuraVax Inc. Filings

Explore SEC and related filing metadata, where available.

DuraVax Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DuraVax Inc.'s valuation, stock price, and market status.

Is DuraVax Inc. a public or private company?

DuraVax Inc. is a private company.

What is the current stock price of DuraVax Inc.?

DuraVax Inc. is a private company with no public stock price. Caplight tracks DuraVax Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is DuraVax Inc. worth (valuation)?

Valuation information for DuraVax Inc. is not publicly available.

Can I buy DuraVax Inc. stock?

DuraVax Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DuraVax Inc.'s last funding round?

DuraVax Inc.'s most recent funding round was Grant on May 1, 2024.

Who are the main investors in DuraVax Inc.?

Key investors in DuraVax Inc. include NCInnovation, North Carolina Biotechnology Center, National Science Foundation.

Will DuraVax Inc. IPO soon?

No public IPO plans have been announced for DuraVax Inc..

How can I track DuraVax Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DuraVax Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWilmington, North Carolina
Year Founded2023
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?